Generation of sarcolipin heart-specific transgenic mice and molecular mechanism of atrial chamber-specific expression
肌磷脂心脏特异性转基因小鼠的产生及心房特异性表达的分子机制
基本信息
- 批准号:15500288
- 负责人:
- 金额:$ 2.3万
- 依托单位:
- 依托单位国家:日本
- 项目类别:Grant-in-Aid for Scientific Research (C)
- 财政年份:2003
- 资助国家:日本
- 起止时间:2003 至 2004
- 项目状态:已结题
- 来源:
- 关键词:
项目摘要
I. Cardiac dysfunction sarcolipin heart-specific transgenic miceIn vivo echocardiography and hemodynamic study demonstrated that cardiac function, especially diastolic function was impaired in sarcolipin (SLN) heart-specific transgenic mice when compared with those in age-matched control mice. Although SIN heart-specific transgenic mice did not exhibited either cardiac hypertrophy or dilation, molecular markers of cardiac hypertrophy such as ANF and BNP were up regulated, suggesting masked cardiac remodeling in SLN heart-specific transgenic mine. These data indicate that SLN play an important role in atrial function via regulation of SERCA2a activity.II. Anaiysisi of mouse sarcolipin promoter and its transcriptional regulationWe cloned a 2.3-kilobase pair DNA fragment encompassing the 5'-flanking region of the mouse SLN gene and examined the effect of retinoic acid on its promoter activity. Transient transfection of H9C2 with F1-luciferase (-2237 to +62 nucleotides) yielded a 40-fold increase in promoter activity. Transient transfection of a series of 5'→3' deletion constructs of F1-luciferase suggested that the minimal region for full activation of the SLN promoter activity is located up to -326 nucleotides and that negative regulatory elements of RA were located between -2237 and -326 nucleotides. The present data indicate that the expression of SLN mRNA is likely regulated by retinoic acid, at least in part, at transcriptional level. In addition, we found that pressure overload, retinoic acid and thyroid hormono down-regulated the expression of SLN mRNAs.
I.心肌特异性转基因鼠心功能障碍的研究心肌特异性转基因鼠心脏特异性转基因鼠心功能障碍的研究虽然SIN心脏特异性转基因小鼠没有表现出心脏肥大或扩张,但心脏肥大的分子标志物如ANF和BNP上调,表明SLN心脏特异性转基因小鼠的心脏重塑被掩盖。这些数据表明SLN通过调节SERCA 2a活性在心房功能中发挥重要作用。本研究克隆了小鼠肌磷脂基因5 ′侧翼区的2.3-磷酸酶对DNA片段,并研究了视黄酸对其启动子活性的影响。用F1-荧光素酶(-2237至+62个核苷酸)瞬时转染H9 C2产生启动子活性的40倍增加。瞬时转染一系列5 '→ 3'缺失的F1-荧光素酶构建体表明,SLN启动子活性完全激活的最小区域位于-326个核苷酸,RA的负调控元件位于-2237和-326个核苷酸之间。目前的数据表明,SLN mRNA的表达可能是由视黄酸,至少部分,在转录水平上进行调节。此外,我们还发现压力超负荷、维甲酸和甲状腺激素可下调SLN mRNA的表达。
项目成果
期刊论文数量(40)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
Minamisawa S et al.: "Atrial-chamber specific expression of sarcolipin is regrlated during development and hypertrophic remodeling"J Biol Chem. 278・11. 9570-9575 (2003)
Minamisawa S 等:“肌磷脂的心房特异性表达在发育和肥大重塑过程中受到调节”J Biol Chem 278・11 (2003)。
- DOI:
- 发表时间:
- 期刊:
- 影响因子:0
- 作者:
- 通讯作者:
Junctophilin type 2 is associated with caveolin-3 and is down-regulated in the hypertrophic and dilated cardiomyopathies
- DOI:10.1016/j.bbrc.2004.10.107
- 发表时间:2004-12-17
- 期刊:
- 影响因子:3.1
- 作者:Minamisawa, S;Oshikawa, J;Matsuoka, R
- 通讯作者:Matsuoka, R
Calcium cycling proteins in heart failure, cardiomyopathy and arrhythmias
- DOI:10.1038/emm.2004.27
- 发表时间:2004-06-30
- 期刊:
- 影响因子:12.8
- 作者:Minamisawa, S;Sato, Y;Cho, MC
- 通讯作者:Cho, MC
Juncophilin type 2 is associated with caveolin-3 and is down-regulated in the hypertrophic and dilated cardiomyopathies.
2 型 Juncophilin 与 Caveolin-3 相关,在肥厚型和扩张型心肌病中表达下调。
- DOI:
- 发表时间:2004
- 期刊:
- 影响因子:0
- 作者:Matsuyama K;Mori F;Nakajima K;Drew T;Aoki M;Mori S.;Minamisawa S et al.
- 通讯作者:Minamisawa S et al.
Minamisawa S et al.: "Mutation of the phospholanbam promoter associated with hypertrophic cardiomyopathy"Biochem Biophys Res Commun. 304・1. 1-4 (2003)
Minamisawa S等:“与肥厚型心肌病相关的磷蛋白启动子的突变”Biochem Biophys Res Commun. 304·1(2003)。
- DOI:
- 发表时间:
- 期刊:
- 影响因子:0
- 作者:
- 通讯作者:
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
MINAMISAWA Susumu其他文献
MINAMISAWA Susumu的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('MINAMISAWA Susumu', 18)}}的其他基金
Search for a promoting factor of internal elastic lamina formation derived from endothelial cells
寻找内皮细胞来源的内弹力层形成的促进因子
- 批准号:
26670096 - 财政年份:2014
- 资助金额:
$ 2.3万 - 项目类别:
Grant-in-Aid for Challenging Exploratory Research
Molecular mechanisms of ductus arteriosus closure
动脉导管闭合的分子机制
- 批准号:
23390277 - 财政年份:2011
- 资助金额:
$ 2.3万 - 项目类别:
Grant-in-Aid for Scientific Research (B)
Mechanical stimulation-induced vascular elastogenesis
机械刺激诱导血管弹性生成
- 批准号:
22659045 - 财政年份:2010
- 资助金额:
$ 2.3万 - 项目类别:
Grant-in-Aid for Challenging Exploratory Research
Molecular mechanisms of closure of the ductus arteriosus
动脉导管闭合的分子机制
- 批准号:
20390300 - 财政年份:2008
- 资助金额:
$ 2.3万 - 项目类别:
Grant-in-Aid for Scientific Research (B)
The effect of aging and pressure overload on the heart of SERCA2a mutant mice
衰老和压力超负荷对SERCA2a突变小鼠心脏的影响
- 批准号:
18590782 - 财政年份:2006
- 资助金额:
$ 2.3万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
Is the enhancement of the sarcoplasmic reticulum function susceptible to arrhythmias?
肌浆网功能增强是否易发生心律失常?
- 批准号:
13670748 - 财政年份:2001
- 资助金额:
$ 2.3万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
相似海外基金
Modulation of heart function by Muscle LIM protein-mediated mechanotransduction
肌肉 LIM 蛋白介导的机械转导调节心脏功能
- 批准号:
10645223 - 财政年份:2022
- 资助金额:
$ 2.3万 - 项目类别:
Modulation of heart function by Muscle LIM protein-mediated mechanotransduction
肌肉 LIM 蛋白介导的机械转导调节心脏功能
- 批准号:
10503955 - 财政年份:2022
- 资助金额:
$ 2.3万 - 项目类别:
Elucidation of the Role of a Novel Cardiac Micropeptide in the Control of Heart Function and Dysfunction
阐明新型心脏微肽在控制心脏功能和功能障碍中的作用
- 批准号:
8982744 - 财政年份:2016
- 资助金额:
$ 2.3万 - 项目类别:
Elucidation of the Role of a Novel Cardiac Micropeptide in the Control of Heart Function and Dysfunction
阐明新型心脏微肽在控制心脏功能和功能障碍中的作用
- 批准号:
9205181 - 财政年份:2016
- 资助金额:
$ 2.3万 - 项目类别:
Modulating stretch activation to restore muscle and heart function
调节拉伸激活以恢复肌肉和心脏功能
- 批准号:
8874907 - 财政年份:2014
- 资助金额:
$ 2.3万 - 项目类别:
Modulating stretch activation to restore muscle and heart function
调节拉伸激活以恢复肌肉和心脏功能
- 批准号:
9099746 - 财政年份:2014
- 资助金额:
$ 2.3万 - 项目类别:
Cardiac Remodeling, Signaling, Matrix and Heart Function
心脏重塑、信号传导、基质和心脏功能
- 批准号:
8527455 - 财政年份:2013
- 资助金额:
$ 2.3万 - 项目类别:
RIGHT HEART FUNCTION IN PULMONARY HYPERTENSION WITH BETA-AGONIST AND ATRIAL SHUNT
β 受体激动剂和心房分流术治疗肺动脉高压时的右心功能
- 批准号:
8051757 - 财政年份:2008
- 资助金额:
$ 2.3万 - 项目类别: